Japan
· Delayed Price · Currency is JPY Daiken Medical Statistics
Total Valuation
Daiken Medical has a market cap or net worth of JPY 14.42 billion. The enterprise value is 13.79 billion.
| Market Cap | 14.42B |
| Enterprise Value | 13.79B |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Daiken Medical has 28.73 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 28.73M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.78% |
| Owned by Institutions (%) | 5.55% |
| Float | 14.17M |
Valuation Ratios
The trailing PE ratio is 13.64 and the forward PE ratio is 13.49.
| PE Ratio | 13.64 |
| Forward PE | 13.49 |
| PS Ratio | 1.44 |
| PB Ratio | 1.96 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.04 |
| EV / Sales | 1.38 |
| EV / EBITDA | 8.13 |
| EV / EBIT | 9.06 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.33 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 226.86 |
Financial Efficiency
Return on equity (ROE) is 14.79% and return on invested capital (ROIC) is 9.93%.
| Return on Equity (ROE) | 14.79% |
| Return on Assets (ROA) | 8.43% |
| Return on Invested Capital (ROIC) | 9.93% |
| Return on Capital Employed (ROCE) | 18.28% |
| Revenue Per Employee | 57.20M |
| Profits Per Employee | 6.04M |
| Employee Count | 175 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 4.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.80% in the last 52 weeks. The beta is -0.11, so Daiken Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -11.80% |
| 50-Day Moving Average | 504.84 |
| 200-Day Moving Average | 518.87 |
| Relative Strength Index (RSI) | 51.87 |
| Average Volume (20 Days) | 38,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daiken Medical had revenue of JPY 10.01 billion and earned 1.06 billion in profits. Earnings per share was 36.80.
| Revenue | 10.01B |
| Gross Profit | 4.13B |
| Operating Income | 1.52B |
| Pretax Income | 1.51B |
| Net Income | 1.06B |
| EBITDA | 1.70B |
| EBIT | 1.52B |
| Earnings Per Share (EPS) | 36.80 |
Balance Sheet
The company has 2.97 billion in cash and 2.34 billion in debt, giving a net cash position of 633.01 million or 22.03 per share.
| Cash & Cash Equivalents | 2.97B |
| Total Debt | 2.34B |
| Net Cash | 633.01M |
| Net Cash Per Share | 22.03 |
| Equity (Book Value) | 7.38B |
| Book Value Per Share | 256.75 |
| Working Capital | 4.10B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 15.20% |
| Pretax Margin | 15.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 3.58%.
| Dividend Per Share | 18.00 |
| Dividend Yield | 3.58% |
| Dividend Growth (YoY) | 4.76% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 3.58% |
| Earnings Yield | 7.33% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 13, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Nov 13, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |